Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Immucell Cp (ICCC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,990
  • Shares Outstanding, K 5,480
  • Annual Sales, $ 10,430 K
  • Annual Income, $ -170 K
  • 36-Month Beta 1.04
  • Price/Sales 3.55
  • Price/Cash Flow 50.95
  • Price/Book 1.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.75 unch
on 06/22/18
7.30 -7.53%
on 05/23/18
-0.40 (-5.59%)
since 05/21/18
3-Month
6.70 +0.82%
on 03/28/18
8.65 -21.97%
on 05/09/18
-0.30 (-4.26%)
since 03/22/18
52-Week
5.26 +28.33%
on 09/11/17
9.25 -27.03%
on 11/27/17
+0.25 (+3.85%)
since 06/22/17

Most Recent Stories

More News
ImmuCell Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / ImmuCell Corporation (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern Time.

ICCC : 6.75 (-1.32%)
ImmuCell Announces Financial Results for First Quarter of 2018

ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health...

ICCC : 6.75 (-1.32%)
ImmuCell to Announce Financial Results for First Quarter of 2018

ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health...

ICCC : 6.75 (-1.32%)
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health...

ICCC : 6.75 (-1.32%)
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017

ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health...

ICCC : 6.75 (-1.32%)
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares

ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health...

ICCC : 6.75 (-1.32%)
ImmuCell Announces Completion of Construction of Nisin Production Facility

ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle,...

ICCC : 6.75 (-1.32%)
ImmuCell Announces Expansion of Sales and Marketing Team

ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries,...

ICCC : 6.75 (-1.32%)
ImmuCell Announces Financial Results for Second Quarter of 2017

ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries,...

ICCC : 6.75 (-1.32%)
Investor Network: ImmuCell Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / ImmuCell Corporation (NASDAQ: ICCC) will be discussing their earnings results in their Q2 Earnings Call to be held on Monday, August 14, 2017 at 4:30 PM Eastern...

ICCC : 6.75 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade ICCC with:

Business Summary

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM,...

See More

Key Turning Points

2nd Resistance Point 6.86
1st Resistance Point 6.80
Last Price 6.75
1st Support Level 6.72
2nd Support Level 6.70

See More

52-Week High 9.25
Fibonacci 61.8% 7.73
Fibonacci 50% 7.26
Fibonacci 38.2% 6.78
Last Price 6.75
52-Week Low 5.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar